Nivolumab is a human IgG4 monoclonal antibody that inhibits the programmed death receptor-1 (PD-1) pathway, offering therapeutic benefits in the management of advanced (metastatic) non-small cell lung cancer. This antibody functions by blocking the interaction between PD-1 and its ligands, thereby enhancing the immune response against tumor cells. It is specifically designed for the treatment of patients with advanced stages of this malignancy, where it has shown efficacy in improving patient outcomes.
Nivolumab is a human IgG4 monoclonal antibody that inhibits the programmed death receptor-1 (PD-1) pathway, offering therapeutic benefits in the management of advanced (metastatic) non-small cell lung cancer. This antibody functions by blocking the interaction between PD-1 and its ligands, thereby enhancing the immune response against tumor cells. It is specifically designed for the treatment of patients with advanced stages of this malignancy, where it has shown efficacy in improving patient outcomes.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula: